ARRADX
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

ARRADX Trademark

Serial Number: 78520404

ARRADX is a trademark filed by ArraDx Limited by change of name from Arragen Limited on November 19, 2004. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

ArraDx Limited by change of name from Arragen Limited (2 trademarks)

Almac House
Craigavon BT63 5 QD , IE

Entity Type: 99

Trademark Details

Filing Date

November 19, 2004

Registration Date

Not Registered

Goods & Services

pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; biochemical preparations for use in diagnosis of cancer; biochemical preparations for diagnostic use; diagnostic preparations for medical purposes; diagnostic products for medical purposes; diagnostic tools; cancer diagnostic preparations, products and tools; microarray based diagnostic tools; microarray based diagnostic tools for cancer diagnosis; clinical diagnostics for medical use; agents of biological origin for use in the diagnosis of disease and cancer; diagnostic kits; pharmaceutical preparations; biochemical preparations for diagnostic use; diagnostic preparations for medical purposes; diagnostic products for medical purposes; diagnostic tools; microarray based diagnostic tools; clinical diagnostics for medical use; agents of biological origin for use in the diagnosis of diseases

medical apparatus and instruments; diagnostic apparatus for medical purposes; apparatus for medical diagnosis; diagnostic products for medical purposes; diagnostic tools; cancer diagnostic products and tools; microarray based diagnostic tools; microarray based diagnostic tools for cancer diagnosis clinical diagnostics for medica; use; agents of biological origin for use in the diagnosis of disease and cancer; diagnostic kits; and parts therefor

biological research, development and testing; biotechnology; biotechnology research, development and testing; bioinformatics; research and development of diagnotic tools; research and development of diagnotic tools for cancer and the cancer market; development of microarray based diagnostic tools; development and clinical validation of diagnostic products; development and clinical validation of cancer diagnostic products; microarray research; microarray services for academic institutions, and for the biotechnology and pharmaceutical industries; design and conduct for experiments; data analysis services; microarray data analysis services; statistical analysis; analysis of microarray; infromation services for facilitating and promoting the gathering, evaluations and dissemination of information relating to clinical trials and/or the efficacy and effects of various medical treatments; information services for facilitating and promoting the gathering, evaluation and dissemination of information relating to clinical trials trials and/or the efficacy and efforts and effects of various medical treatments by means of a global computer network or the Internet; services for assessing the efficiency, efficacy, effects and safety of drugs and medical treatments; information, advisory, advisory and consultancy services relating to the aforementioned services; biological research, development and testing; biotechnology; biotechnology research, development and testing; bioinformatics; research and development of diagnostic tools; research and development of diagnostic tools for cancer and the cancer market; development of micrroarray based diagnostic tools; development and clinical validation of diagnostic products; development and clinical validation of cancer diagnostic products; microarray research; microarray services for academic institutions, and for the biotechnology and pharmaceutical industries; design and conduct of experiments; data analysis services; microarray data analysis services; statistical analysis; analysis of microarrays; information, advisory and consultancy services relating to the aforementioned services

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jan 23, 2006 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 23, 2006 ABN2
NON-FINAL ACTION MAILED
Jun 27, 2005 CNRT
NON-FINAL ACTION WRITTEN
Jun 24, 2005 CNRT
ASSIGNED TO EXAMINER
Jun 24, 2005 DOCK
NEW APPLICATION ENTERED
Nov 30, 2004 NWAP